Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma

British Journal of Cancer

Volumn 73, Issue 5, 1996, Pages 649-653

  Waring, A J ^a   Takata, M ^a,b   Rehman, I ^a   Rees, J L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Benign cell papilloma; Keratoacanthoma; Loss of heterozygosity; Multiple self healing squamous epithelioma; p53; Squamous cell carcinoma

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; BENIGN TUMOR; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 9P; CHROMOSOME 9Q; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENE LOSS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; HYPOTHESIS; KERATOACANTHOMA; PRIORITY JOURNAL; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA;

EID: 0030069445     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.113     Document Type: Article

References (50)

1. BRASH DE, RUDOLPH JA, SIMON JA, LIN A, MCKENNA GJ, BADEN HP, HALPERIN AJ AND PONTEN J. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA, 88, 10124-10128.
2. BURNS PA, BREMNER R AND BALMAIN A. (1991). Genetic changes during mouse skin tumorigenesis. Environ. Health Perspect., 93, 41-44.
3. CAMPBELL C, QUINN AG, ANGUS B AND REES JL (1993a). The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Br. J. Dermatol., 129, 235-241.
4. CAMPBELL C, QUINN AG, RO YS, ANGUS B AND REES JL. (1993b). p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J. Invest. Dermatol., 100, 746-748.
5. COROMINAS M, KAMINO H, LEON J AND PELLICER A. (1989). Oncogene activation in human benign tumors of the skin (keratoacanthomas) : is H-ras involved in differentiation as well as proliferation. Proc. Natl Acad. Sci. USA, 86, 6372-6376.
6. FARNDON PA, DEL MASTRO RG, EVANS DGR AND KILPATRICK MW. (1992). Location of gene for Gorlin syndrome. Lancet, 339, 581-582.
7. FEARON ER AND VOGELSTEIN B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
8. GAILANI MR, BALE SJ, LEFEEL DJ, DIGIOVANNA JJ, PECK GL, POLLAK S, DRUM MA, PASTAKIA B. MCBRIDE OW, KASE R, GREENE M, MULVIHILL JJ AND BALE AE. (1992). Developmental defects in Gorlin's syndrome related to a putative tumor suppressor gene on chromosome 9. Cell, 69, 111-117.
9. GASSENMAIER A, PFISTER H AND HORNSTEIN OP. (1986). Human papillomavirus 25-related DNA in solitary keratoacanthoma. Arch. Dermatol. Res., 279, 73-76.
10. GHADIALLY R AND GHADIALLY FN. (1993). Keratoacanthoma. In Dermatology in General Medicine, Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM and Austen KF. (eds) pp. 848-855. McGraw-Hill: New York.
11. GOUDIE DR, YULLE MAR, LEVERSHA MA, FURLONG RA, CARTER NP, LUSH MJ, AFFARA NA AND FERGUSON-SMITH MA. (1993). Multiple self healing squamous epitheliomata (ESS1) mapped to chromosome 9q22-q31 in families with common ancestry. Nat. Gen., 3, 165-169.
12. HELANDER SD, PETERS MS AND PITTELKOW MR. (1993). Expression of p53 protein in benign and malignant epidermal pathologic conditions. J. Am. Acad. Dermatol., 29, 741-748.
13. HERZBERG AJ, KERNS BJ, POLLACK V AND KINNEY RB. (1991). DNA image cytometry of keratoacanthoma and squamous cell carcinoma. J. Invest. Dermatol., 97, 495-500.
14. JACKSON DP, HAYDEN JD AND QUIRKE P. (1992). Extraction of nucleic acid from fresh and archival material. In PCR, a Practical Approach. McPherson MJ, Quirke P and Taylor GR. (eds) pp. 29-50. Oxford University Press: Oxford.
15. KAMB A, NELLEKE AG, WEAVER-FELDHAUS J, LIU Q, HARSHMAN K, TAVTIGIAN SV, STOCKERKT E, DAY RS, JOHNSON BE AND SKOLNICK MH. (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264, 436-440.
16. KERSCHMANN RL, MCCALMONT TH AND LEBOIT PE. (1994). p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch. Dermatol., 130, 181-185.
17. KUBO Y, URANO Y, YOSHIMOTO K, IWAHANA H, FUKUHARA K, ARASE S AND ITAKURA M. (1994). p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis. J. Invest. Dermatol., 102, 440-444.
18. KWA RE, CAMPANA K AND MOY RL. (1992). Biology of cutaneous squamous cell carcinoma. J. Am. Acad. Dermatol., 26, 1-26.
19. LEE Y-S AND TEH M. (1994). p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin. Cancer, 73, 2317-2323.
20. MACKIE RM. (1992). Epidermal skin tumours. In Textbook of Dermatology, Fifth edn, Champion RH, Burton JL and Ebling FJG. (eds) pp. 1505-1524. Blackwell Scientific: London.
21. MARKS R, FOLEY P, GOODMAN G, HAGE BH AND SELWOOD TS. (1986). Spontaneous remission of solar keratoses: the case for conservative management. Br. J. Dermatol., 115, 649-655.
22. MILLER SJ. (1991a). Biology of basal cell carcinoma (I). J. Am. Acad. Dermatol., 24, 1-13.
23. MILLER SJ. (1991b). Biology of basal cell carcinoma (II). J. Am. Acad. Dermatol., 24, 161-175.
24. MIRACCO C, DE SANTI MM, LIO R, BIAGIOLI M, TOSI P AND LUZI P. (1992). Quantitatively evaluated ultrastructural findings can add to the differential diagnosis between keratoacanthoma and well differentiated squamous cell carcinoma. J. Submicrosc. Cytol. Pathol., 24, 315-321.
25. NEWTON JA, CAMPLEJOHN RS AND MCGIBBON DH. (1987). A flow cytometric study of the significance of DNA aneuploidy in cutaneous lesions. Br. J. Dermatol., 117, 169-174.
26. NOBORI T, MIUIRA K, WU DJ, LOIS A, TAKABAYASHI K AND CARSON DA. (1994). Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
27. OLOPADE OI, BOHLANDER SK, POMYKALA H, MALTEPE E, VAN MELLE E, LE BEAU MM AND DIAZ MO. (1992). Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics, 14, 437-443.
28. PATEL VG, SHUM-SIU A, HENIFORD BW, WIEMAN TJ AND HENDLER FJ. (1994). Detection of epidermal growth factor receptor mRNA in tissue sections from biopsy specimens using in situ polymerase chain reaction. Am. J. Pathol., 144, 7-14.
29. PFISTER H, GASSENMAIER A AND FUCHS PG. (1986). Demonstration of human papillomavirus DNA in two keratoacanthomas. Arch. Dermatol. Res., 278, 243-246.
30. QUINN AG, CAMPBELL C, HEALY E AND REES JL. (1994a). Chromosome 9 allele loss occurs in both basal and squamous cell carcinomas of the skin. J. Invest. Dermatol., 102, 300-303.
31. QUINN AG, SIKKINK S AND REES JL. (1994b). Basal cell carcinomas and squamous cell carcinomas show distinct patterns of chromosome loss. Cancer Res., 54, 4756-4759.
32. QUINN AG, SIKKINK S AND REES JL. (1994c). Delineation of two distinct deleted regions on chromosome 9 in human non-melanoma skin cancers. Genes Chromosom. Cancer, 11, 222-225.
33. RAMSELAAR CG AND VAN DER MEER JB. (1976). The spontaneous regression of keratoacanthoma in man. Acta Derm. Venereol. (Stockh)., 56, 245-251.
34. RAMSELAAR CG AND VAN DER MEER JB. (1979). Non-immunological regression of dimethylbenz(A) anthracene-induced experimental keratoacanthomas in the rabbit. Dermatologica, 158, 142-151.
35. RAMSELAAR CG, RUITENBERG EJ AND KRUIZINGA W. (1980). Regression of induced keratoacanthomas in anagen (hair growth phase) skin grafts in mice. Cancer Res., 40, 1668-1673.
36. REES JL. (1994). Genetic alterations in non-melanoma skin cancer. J. Invest. Dermatol., 103, 747-750.
37. REHMAN I, QUINN AG, HEALY E AND REES JL. (1994). High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease. Lancet, 344, 788-789.
38. SCHWARTZ RA. (1994). Keratoacanthoma. J. Am. Acad. Dermatol., 30, 1-19.
39. SEIDMAN JD, BERMAN JJ, MOORE GW AND YETTER RA. (1992). Multiparameter DNA flow cytometry of keratoacanthoma. Anal. Quant. Cytol. Histol., 14, 113-119.
40. STEPHENSON TJ, ROYDS J, SILCOCKS PB AND BLEEHAN SS. (1992). Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma. Br. J. Dermatol., 127, 566-570.
41. STEPHENSON TJ, ROYDS JA, BLEEHEN SS, SILCOCKS PB AND REES RC. (1993). 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma. Dermatology, 187, 95-99.
42. STRAKA BF AND GRANT-KELS JM. (1991). Keratoacanthoma. In Cancer of the Skin, Friedman RJ, Rigel DS, Kopf AW, Harris MN and Baker D. (eds.) pp. 390-407. WB Saunders: Philadelphia.
43. WEAVER-FELDHAUS J, GRUIS NA, NEUHAUSEN S, LE PASLIER D, STOCKERT E, SKOLNICK MH AND KAMB A. (1994). Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc. Natl Acad. Sci. USA, 91, 7563-7567.
44. WEINBERG RA. (1991). Oncogenes, tumour suppressor genes, and cell transformation : trying to put it all together. In Origins of Human Cancer, Brugge J, Curran T, Harlow E and McCormick F. (eds) pp. 1-16. Cold Spring Harbor Laboratory Press: New York.
45. WEINSTOCK MA. (1994). Epidemiology of nonmelanoma skin cancer: clinical issues, definitions, and classification. J. Invest. Dermatol. 102, 4S-5S.
46. WEISSENBACH J. GYAPAY G, DIB C, VIGNAL A, MILLASSEAU P, VAYSSEIX G AND LATHROP M. (1992). A second generation linkage map of the human genome. Nature, 359, 794-801.
47. WITTEN VH AND ZAK FG (1952). Multiple, primary, self-healing prickle-cell epithelioma of the skin. Cancer, 5, 539.
48. YOKOTA J AND SUGIMURA T. (1993). Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J., 7, 920-925.
49. ZIEGLER A, LEFFELL DJ, KUNALA S, SHARMA HW, GAILANI M, SIMON JA, HALPERIN AJ, BADEN HP, SHAPIRO PE, BALE AE AND BRASH DE. (1993). Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl Acad. Sci. USA, 90, 4216-4220.
50. ZIEGLER A, JONASON AS, LEFFELL DJ, SIMON JA, SHARMA HW, KIMMELMAN J, REMINGTON L, JACKS T AND BRASH DE. (1994). Sunburn and p53 in the onset of skin cancer. Nature, 372, 773-776.